Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Cash Flow Reinvestment Rate
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Cash Flow Reinvestment Rate of 0.46x as of September 2025, reinvesting CN¥32.02 Million (capex CN¥32.02 Million ) from operating cash flow of CN¥69.15 Million. See free cash flow generation of Anhui Fengyuan Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Anhui Fengyuan Pharmaceutical Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see 000153 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Anhui Fengyuan Pharmaceutical Co Ltd. See financial agility of Anhui Fengyuan Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.27x | CN¥270.65 Million | CN¥119.30 Million | CN¥220.61 Million | ▲ +13.7% |
| 2024 | 2.00x | CN¥251.93 Million | CN¥126.24 Million | CN¥144.02 Million | ▲ +222.8% |
| 2023 | 0.62x | CN¥157.48 Million | CN¥254.75 Million | CN¥152.12 Million | ▲ +150.1% |
| 2022 | 0.25x | CN¥108.76 Million | CN¥439.99 Million | CN¥81.76 Million | ▼ -64.2% |
| 2021 | 0.69x | CN¥164.26 Million | CN¥237.88 Million | CN¥157.36 Million | ▼ -25.2% |
| 2020 | 0.92x | CN¥270.07 Million | CN¥292.75 Million | CN¥190.74 Million | ▼ -83.3% |
| 2019 | 5.54x | CN¥366.62 Million | CN¥66.21 Million | CN¥145.62 Million | ▲ +600.4% |
| 2018 | 0.79x | CN¥184.65 Million | CN¥233.59 Million | CN¥84.63 Million | ▼ -21.3% |
| 2017 | 1.00x | CN¥52.60 Million | CN¥52.40 Million | CN¥47.99 Million | ▲ +70.2% |
| 2016 | 0.59x | CN¥46.15 Million | CN¥78.21 Million | CN¥22.17 Million | ▼ -47.8% |
| 2015 | 1.13x | CN¥51.43 Million | CN¥45.50 Million | CN¥50.33 Million | ▼ -93.2% |
| 2014 | 16.73x | CN¥175.86 Million | CN¥10.51 Million | CN¥175.86 Million | ▲ +703.5% |
| 2012 | 2.08x | CN¥95.06 Million | CN¥45.65 Million | CN¥95.06 Million | ▲ +64.1% |
| 2011 | 1.27x | CN¥69.86 Million | CN¥55.06 Million | CN¥69.86 Million | ▼ -22.2% |
| 2010 | 1.63x | CN¥89.75 Million | CN¥55.04 Million | CN¥89.75 Million | ▼ -29.0% |
| 2009 | 2.30x | CN¥74.42 Million | CN¥32.41 Million | CN¥74.42 Million | ▲ +262.3% |
| 2008 | 0.63x | CN¥31.58 Million | CN¥49.82 Million | CN¥31.58 Million | ▼ -0.4% |
| 2007 | 0.64x | CN¥35.18 Million | CN¥55.26 Million | CN¥35.18 Million | ▼ -83.1% |
| 2006 | 3.77x | CN¥136.67 Million | CN¥36.27 Million | CN¥136.67 Million | ▲ +268.4% |
| 2005 | 1.02x | CN¥35.68 Million | CN¥34.88 Million | CN¥35.68 Million | ▼ -88.3% |
| 2002 | 8.73x | CN¥91.40 Million | CN¥10.48 Million | CN¥91.40 Million | ▲ +8.1% |
| 2001 | 8.07x | CN¥190.24 Million | CN¥23.57 Million | CN¥190.24 Million | ▲ +77.3% |
| 2000 | 4.55x | CN¥117.82 Million | CN¥25.88 Million | CN¥117.82 Million | ▲ +0.5% |
| 1999 | 4.53x | CN¥4.59 Million | CN¥1.01 Million | CN¥4.59 Million | — |